Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery-The RECOVER Study

Next Previous
Trial Profile

Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery-The RECOVER Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 06 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Opioid-related disorders
  • Focus Therapeutic Use
  • Acronyms RECOVER
  • Sponsors Indivior

    • Most Recent Events

    • 01 May 2022 Results investigating diverse array of outcomes for individuals with OUD at an average of 4.2 years post clinical trial participation from NCT023579011; NCT025100142; NCT02896296 & NCT03604861 were published in the Drug and Alcohol Dependence.
    • 24 Jun 2020 According to an Indivior media release, Warren K. Bickel, a professor at Fralin Biomedical Research Institute at Virginia Tech Carilion, is leading the next phase of this RECOVER study, which researchers hope will provide further information to health care systems and policymakers on how continuity of care can help address the nations opioid crisis.
    • 24 Jun 2020 According to an Indivior media release, Walter Ling, MD, (Research Professor, Department of Family Medicine, David Geffen School of Medicine, UCLA) is the lead author of this study.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top